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ABSTRACT 
The purpose of this study was to evaluate the efficacy of CONSTAC PLUS granulation in the management of 
severe chronic constipation. Total 450 patients were enrolled to receive a CONSTAC PLUS for maximum 60 
days. Out of 450 patients, 33 were lost to follow up. The symptoms of constipation were evaluated by Longo’s 
Obstructed Defecation Syndrome (ODS) score system. Patients’ quality of life was assessed by the Patient 
Assessment of Constipation-Quality of Life Questionnaire and stool consistency were assessed by “Bristol 
stool form scale” before and after 15, 30 and 60 days. Analysis done for 417 patients. After treatment there 
was significant (p<0.005) improvement in defecation frequency per week. There was significant reduction in 
rectoperinieal pain and discomfort, straining intensity, average time spent on toilet for bowel evacuation and 
digitations score. Stool consistency were significantly (p<0.005) improved in all follow-up visits. Quality of 
life also significantly improved in all follow up visits. During study abdominal pain/cramping (n= 13/ 3.12%), 
bloating (n= 11/ 2.64%), diarrhea (n= 9/ 2.16%), and passing gas (n= 17/ 4.098%) adverse events were 
more commonly reported. All were treated by medical management. This result proves CONSTAC PLUS is an 
effective and safe herbal laxative formulation for severe chronic constipation. 
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INTRODUCTION 
 Chronic constipation is infrequent bowel 
movements or difficult passage of stools that persists for 
several weeks or longer in elderly with considerable 
impact on quality of life and health expenses. It has a 
prevalence around 15–17% of adults and characterized by 
unsatisfying defecation associated with infrequent stools, 
difficult stool pass.[1,2] Most cases of chronic constipation 
are primary or idiopathic, but a some cases may be 
secondary to a number of medications or diseases.[3] For 
diagnosis of constipation “Rome III ” is one of the most 
widely accepted criteria.[4] Treatment of constipation 
includes patient education, dietary fiber supplementation, 
adequate fluid intake, and regular physical activity.[5] 
Approximately 25% patients uses medical treatments, 
whereas a considerable proportion relies on alternative 
solutions, following advices given in pharmacies or 
herbalist’s shops.[6] Depending on severity and chronicity 
of constipation various drugs such as osmotic agents, 
stimulants, stool softeners and bulk-forming agents are 
used, but they have side effects like abdominal cramping, 
hypokalemia, flatulence, abdominal distension, and 
alteration in electrolyte transportation which limit the 
long-term use of these drugs.[7-9] CONSTAC PLUS is an 
Ayurvedic polyherbal formulation in granulation form. All 
the ingredients of the formulation have been used for 
thousands of years and individual therapeutic efficacy of 
these herbs as laxative has also been reported in an 
ancient Ayurvedic literature.[10-12] Hence, a pilot study was 
performed to evaluate the efficacy and safety of "CONSTAC 
PLUS" in patients with severe chronic constipation. 
MATERIAL AND METHOD 
Study design: This was an open-label, uncontrolled, Single 
arm, single-center study. 
Study Drug  
 CONSTAC PLUS is an Ayurvedic polyherbal 
formulation in granulation form which comprises dried 
granulations of Hirada and bal Hirada (Terminalia 
chebula), Behada (Terminalia Belerica), Amala (Emblica 
officinalis), Badishep (Foeniculum Vulgare), Elaichi 
(Elettaria cardamomum) Narikel lavan (processed salt with 
coconut), Sonamukhi (Cassia senna), Mulethi (Glycyrhiza 
glabra), Nishottar (Ipomoea turpethum), Erand tail (Caster 
oil). 
Participant 
 We enrolled patients meeting the Rome III 
diagnostic criteria and patients with a stool form score 
ranging from 1 to 3 on the "Bristol Stool Form Scale from 
Healing Hand Clinic, Pune, one of the leading Proctology 
clinics in India. Patients with colorectal cancer, anal 
abscess, anal fissure, rectocele, inflammatory bowel 
disease, megacolon or mechanical bowel obstruction, 
unknown cause of gastrointestinal bleeding or acute 
infection, history of alcohol or drug abuser, women who 
are pregnant, received herb therapy within one month 
prior to enrollment were excluded.  
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Study intervention: All subjects gave written informed 
consent, then patient was recruited in the study if he/she 
fulfilled all the eligibility criteria. All patients completed a 
detailed questionnaire for assessing symptoms of 
constipation by Longo’s ODS score system, stool 
consistency by Bristol stool form scale and quality of life 
by Patient Assessment of Constipation-Quality of Life 
Questionnaire (PAC-QOL). The patient received CONSTAC 
PLUS granulation 2 tablespoon at night with a glass of 
warm water for maximum 60 days. The patient was called 
for follow up on 15th, 30th and 60th days after the baseline 
visit.  
Statistical analysis  
 All analyses were performed using SPSS version 
21.0 software. Data describing quantitative measures were 
expressed as median or mean (SD). Comparison of 
variables representing categorical data was performed 
using "Chi-square test" or "Fisher's exact test." Group 
means of dependent sample were compared by means of 
ANOVA (repeated-measures design, generalized linear 
model procedure) or Wilcoxon sign rank test. 
Corresponding contrasts were tested using t-test for 
dependent samples and nonparametric test like "Wilcoxon 
Sign Rank" Test. p value <0.05 was considered to be 
statistically significant.  
RESULT  
 Total 450 patients enrolled in the study out of that 
33 patients were lost to follow up. An analysis done for 
417 patients out of that, 287 (68.82%) were men while 
31.18 (31.18%) were women and the mean age was 39.77 
± 13.08 years. Study treatment did not cause any 
significant change in vital signs like pulse rate, body 
temperature, respiratory rate, and the blood pressure.  
After treatment there was significant (p<0.005) 
improvement in defecation frequency per week from 
baseline 2.76±0.89 to 7.55±0.43 on Day 60. Mean straining 
intensity score significantly decreased from baseline 
2.09±0.54 to 0.25±0.16 on Day 60. Average time spent on 
toilet for bowel evacuation was significantly decreased 
significantly from a baseline 2.45±0.61to 0.39±0.41 on Day 
60. Sensation of incomplete of evacuation mean score 
improved from baseline 12.67±1.17 to 0.21±0.11 on Day 
60. Mean rectoperinieal pain and discomfort were 
significantly decreased from baseline 2.89±1.04 to 
0.23±0.45. Mean activity reduction per week score 
improved from 3.01±1.84 to 1.65 (1.54) 0.47±0.77 on Day 
60. Mean Digitation score decreased from baseline 
2.87±2.77 to 0.24±0.47on Day 60. (Table 1) 
 Stool consistency were significantly (p<0.005) 
improved on all the three follow-up visits, as shown in 
(assessed on a Bristol stool form scale), as shown in (Table 
2). Total score of PAC-QOL and scores for each of the 
subscales (worries and concerns, physical discomfort, 
psychosocial discomfort, and satisfaction) significantly 
improved (p<0.005) from baseline to end of treatment, as 
shown in (Table 3). 
 During study adverse effects affecting the lower 
gastrointestinal tract (abdominal pain/cramping (n= 13/ 
3.12%), bloating (n= 11/ 2.64%), diarrhea (n= 9/ 2.16%), 
and passing gas (n= 17/ 4.098%) were more common. 
Such side effects are common among laxatives and may be 
related to the one of the herbal compound of CONSTAC 
PLUS. All were treated by medical management. No major 
complications or serious adverse events were observed 
during the study. 
Table 1: Constipation symptoms on ODS scale 
Study Visits Defecation 
Frequency 
per week 
mean±SD 
Straining 
Intensity 
mean±SD 
Extension of 
time in 
defecation 
mean±SD 
Sensation of 
incomplete of 
evacuation 
mean±SD 
Recto/ perineal 
pain/ discomfort 
mean±SD 
Activity 
reduction 
per week 
mean±SD 
Digitations 
mean±SD 
Day 1 (n=417) 2.76±0.89 2.09±0.54 2.45±0.61 2.67±1.17 2.89±1.04 3.01±1.84 2.87±2.77 
Day 15 (n=417) 5.60±1.07 0.93±0.29 1.82±0.42 1.17±0.79 1.19±0.92 1.98±1.34 1.87±1.53 
Day 30 (n=213) 6.82±0.14 0.34±0.21  0.73±0.54 0.52±0.46 0.64±0.51 1.17±1.01 0.52±0.71 
Day 60 (n=110) 7.55±0.43 0.25±0.16 0.39±0.41 0.21±0.11 0.23±0.45 0.47±0.77 0.24±0.47 
*p<0.005, significant by student ‘t’ test as compared to baseline (Day1) 
Table 2: Stool consistency on Bristol stool form scale 
Study Visits Mean (SD) 
Day 1 (n=417) 2.22±0.52 
Day 15 (n=417) 4.65±0.77 
Day 30 (n=213) 4.13±0.79 
Day 60 (n=110) 4.26±0.71 
*p<0.005, significant by student ‘t’ test as compared to baseline (Day1) 
Table 3: Quality of life during study 
 PAC- QOL Worries and 
concern 
Physical 
discomfort 
Psychosocial 
discomfort 
Satisfaction 
Study Visits Mean±SD Mean±SD Mean±SD Mean±SD Mean±SD 
Day 1 (n=417) 2.67±0.78 2.54±0.96 2.83±1.19 2.36±1.18 1.46±0.88 
Day 15 (n=417) 1.78±0.74 1.45±1.25 1.25±1.19 1.91±1.05 0.71±0.41 
Day 30 (n=213) 0.68±0.59 0.83±0.94 0.79±0.91 0.94±0.87 - 0.14±0.71 
Day 60 (n=110) 0.49±0.52 0.49±0.77 0.71±1.13 0.71±0.75 - 0.64±0.69 
*p<0.005, significant by student ‘t’ test as compared to baseline (Day1) 
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DISCUSSION  
 This study confirms the beneficial effect of 
CONSTAC PLUS on severe chronic constipation. Now a day 
many therapeutic approaches for the treatment of severe 
chronic constipation. Like patient education, exercise, 
dietary fiber supplementation, adequate fluid intake, and 
regular physical activity, osmotic and stimulant laxatives. 
But new pharmacological therapies have different 
mechanisms of action and side effects. Plants have a wide 
range of bioactive principles and comprise a rich source of 
medicines.[13] CONSTAC PLUS is a polyherbal formulation 
in the form of granulation. It contains Triphala, Badishep 
(Foeniculum Vulgare), Elaichi (Elettaria cardamomum) 
Narikel lavan (processed salt with coconut), Mulethi 
(Glycyrhiza glabra), Nishottar (Ipomoea turpethum), 
Sonamukhi (Cassia senna), Erand tail (Caster oil). 
 Triphala is an age old commonly used Ayurvedic 
powdered preparation in Indian systems of medicine. It 
contains Terminalia chebula, Terminalia Belerica, Emblica 
officinalis. Triphala formulation is prescribed in the first 
line treatment of many aliments and is used as laxative, 
detoxifying agent and rejuvenator.[14] Badishep 
(Foeniculum Vulgare) is an aromatic plant which has been 
used for several years as a flavouring herb. It is commonly 
known as Fennel. It is used as a laxative in the treatment of 
mild digestive disorders due to its gastrointestinal effects, 
namely stimulation of motility and, at higher 
concentrations, antispasmodic action.[15] Elettaria 
cardamomum commonly known as “Elaichi” is a perennial 
herb. It is widely used for culinary purpose, cardamom has 
a folkloric repute as carminative, stomachic, diuretic, 
abortificient, antibacterial, antiviral, antifungal. It is useful 
in treatment of constipation, colic, diarrhea, dyspepsia, 
vomiting, headache, epilepsy and cardiovascular 
diseases.[16] Mulethi (Glycyrhiza glabra) has an anti-
allergic, anti-inflammatory, spasmolytic, mild laxative, 
antistress, antidepressive, antiulcer, liver protective, 
estrogenic, emmenagogue, and antidiabetic effect, and is 
widely used in the Indian system of medicine.[17] 
Sonamukhi (Cassia senna) is said to be cathartic, antiseptic, 
antispasmodic, and cleansing. It is one of the most 
commonly used laxative drugs in the Eastern and Western 
countries for the treatment of constipation.[18,19] Nishottar 
(Ipomoea turpethum) is an important herb, used in 
Ayurvedic system of medicine since ages. It is commonly 
used since centuries in Ayurvedic system of Medicine to 
treat fevers, edema, ascites, anorexia, constipation, 
hepatosplenomegaly, intoxication, haemorrhoids, fistula, 
anemia, obesity, abdominal tumors, ulcers/wounds, worm 
infestation, pruritus and other skin disorders.[20] Narikel 
Lavan is Ayurvedic medicine, in powder form and used in 
treatment of gastritis, acidity and abdominal pain.[21] 
Erand tail (Caster oil) belongs to the “stimulant 
laxatives”.[22] It is used for controlling symptoms of 
constipation.[23] The individual therapeutic efficacy of 
these herbs as laxative has also been reported in an 
ancient Ayurvedic literature.[10-12] The exact mechanism of 
action of the CONSTAC PLUS is not clearly understood, but 
his synergistic effect of the different types of laxative 
ingredients has possibly made it a balanced formulation of 
effective management of severe chronic constipation. 
CONCLUSION  
 Our study result proves CONSTAC PLUS is safe 
and effective in the management of severe chronic 
constipation. 
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